The State Office for Combating Financial Crime of North Rhine-Westphalia (Landes…
Berlin, 25 January 2023 – The international law firm ADVANT Beiten has provided comprehensive legal advice to Cipla (EU) Limited, a wholly-owned subsidiary of Cipla Limited (“Cipla”), headquartered in Mumbai, India, on an investment in Ethris GmbH, based in Planegg near Munich. The acquisition of Ethris' shares was made by Cipla (EU) Limited by way of a capital increase.
Based on proprietary platform technologies, Ethris has been developing mRNA therapeutics for diseases with inadequate treatment and for regenerative medicine for more than 10 years. The biotechnology company develops highly effective mRNA-based drugs for administration directly into the upper and lower respiratory tract and by intra-muscular injection.
Cipla is India's third-largest pharmaceutical company and South Africa's third-largest generic drug manufacturer. It has a particular focus on drugs and therapies for respiratory diseases. Cipla became internationally known for its production of low-cost HIV medicines. Founded in 1935, Cipla employs about 23,000 people.
ADVANT Beiten has a strong positioning in the healthcare sector and in advising international clients on investments in the German market.
Advisor Cipla Ltd.:
ADVANT Beiten: Christian Hipp (Antitrust), Benjamin Knorr (Corporate/M&A and Tax, both leading advisors, Berlin), Dr Dietmar O. Reich (Antitrust, Hamburg and Brussels), Wolf J. Reuter (Employment, Berlin), Robert Schmid(Corporate/M&A, Berlin), Dr Christian Ulrich Wolf (Corporate/M&A, Hamburg), Christian Hess (IP/IT, Munich).
Advisor Ethris GmbH:
m law group. Munich
Media Contact
Frauke Reuther
Manager Kommunikation
ADVANT Beiten
+49 (69) 75 60 95 - 570
frauke.reuther@advant-beiten.com
Benjamin Knorr
Rechtsanwalt
ADVANT Beiten
+49 (30) 26471 – 262
benjamin.knorr@advant-beiten.com
